| MacroGenics Signs Second Regional Option-Based Deal with Servier |
Abstract
|
|
Heather Cartwright |
|
| Bayer and Evotec Collaborate to Develop Three Endometriosis Drug Candidates |
Abstract
|
|
Heather Cartwright |
|
| Ablynx and Merck & Co. Partner to Develop Nanobody® Ion Channel Modulators |
Abstract
|
|
Heather Cartwright |
|
| Celgene Gains Buyout Option with VentiRx Cancer Collaboration |
Abstract
|
|
Heather Cartwright |
|
| Roche In-Licenses Galaxy Biotech’s Preclinical FGF2 Antibody Programme |
Abstract
|
|
Heather Cartwright |
|
| Janssen Biotech Licenses Ex-Japan Rights to Astellas’ Oral JAK Inhibitor ASP015K |
Abstract
|
|
Heather Cartwright |
|
| Alfa Wassermann Partners with Theravance to Develop Velusetrag for Gastroparesis |
Abstract
|
|
Heather Cartwright |
|
| Valeant Expands in Ophthalmology with Acquisition of QLT’s Visudyne ® |
Abstract
|
|
Heather Cartwright |
|
| Sanofi Looks to Second-Generation Emerging Markets with Genfar Acquisition |
Abstract
|
|
Heather Cartwright |
|
| Takeda Boosts Global Vaccine Business with LigoCyte Pharmaceuticals Acquisition |
Abstract
|
|
Heather Cartwright |
|
